300 related articles for article (PubMed ID: 32235336)
1. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
[TBL] [Abstract][Full Text] [Related]
2. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
[TBL] [Abstract][Full Text] [Related]
3. BMPR2 inhibits activin and BMP signaling via wild-type ALK2.
Olsen OE; Sankar M; Elsaadi S; Hella H; Buene G; Darvekar SR; Misund K; Katagiri T; Knaus P; Holien T
J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29739878
[TBL] [Abstract][Full Text] [Related]
4. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
5. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
6. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
7. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B.
Olsen OE; Wader KF; Hella H; Mylin AK; Turesson I; Nesthus I; Waage A; Sundan A; Holien T
Cell Commun Signal; 2015 Jun; 13():27. PubMed ID: 26047946
[TBL] [Abstract][Full Text] [Related]
8. Regulation of hepcidin expression by inflammation-induced activin B.
Kanamori Y; Sugiyama M; Hashimoto O; Murakami M; Matsui T; Funaba M
Sci Rep; 2016 Dec; 6():38702. PubMed ID: 27922109
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 2 stimulates noncanonical SMAD2/3 signaling via the BMP type 1A receptor in gonadotrope-like cells: implications for FSH synthesis.
Wang Y; Ho CC; Bang E; Rejon CA; Libasci V; Pertchenko P; Hébert TE; Bernard DJ
Endocrinology; 2014 May; 155(5):1970-81. PubMed ID: 24601881
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
12. Activin A induces neuronal differentiation and survival via ALK4 in a SMAD-independent manner in a subpopulation of human neuroblastomas.
Suzuki K; Kobayashi T; Funatsu O; Morita A; Ikekita M
Biochem Biophys Res Commun; 2010 Apr; 394(3):639-45. PubMed ID: 20226172
[TBL] [Abstract][Full Text] [Related]
13. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
[TBL] [Abstract][Full Text] [Related]
14. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
18. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Canali S; Core AB; Zumbrennen-Bullough KB; Merkulova M; Wang CY; Schneyer AL; Pietrangelo A; Babitt JL
Endocrinology; 2016 Mar; 157(3):1146-62. PubMed ID: 26735394
[TBL] [Abstract][Full Text] [Related]
19. Activation of G
Ebner JK; König GM; Kostenis E; Siegert P; Aktories K; Orth JHC
Bone; 2019 Oct; 127():592-601. PubMed ID: 31376533
[TBL] [Abstract][Full Text] [Related]
20. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]